Deepinder Goyal and Navil Noronha: a study in contrasting exits
And what that says about how far Eternal can push its norm-defying acts
The Ken Podcast
For her, the 'miracle' weight-loss drug is the light at the end of a tunnel
“I am willing to take the risk and give this drug a shot, for I’ve tried and tested almost all anti-obesity means myself—and even failed at some. As a first step, I am banking on other Ozempic users’ experience.”
Meet Alifiya Khan, a health and education reporter at The Ken. Last month, she published a story on Ozempic and how easy it is to procure despite not being officially cleared for sale by the Indian government.
But this isn’t just another health story. Alifiya herself has been suffering from obesity for more than a decade now. For her procuring Ozempic wasn’t just to further a story. She needed it for herself. After trying every fad diet, weight loss pill, and non-invasive procedure, to Alifiya, Ozempic is the light at the end of the tunnel.
In this episode, she joins hosts Snigdha and Rahel to share her story.
Tune in.
P.S. Not sure if you heard, but we hit 1 million downloads this month! We could not be more excited and grateful to you, our listeners. Could you do us a favour? Could you fill in this form and share your feedback? Also drop us a rating!
The Ken’s podcast team is hiring! We are looking for a producer and host with at least 4-5 years of experience in the field. If you are interested or know someone who would be, please write to [email protected] with ‘Application for The Ken Podcasts’ in the subject line.
And what that says about how far Eternal can push its norm-defying acts
The Walmart-backed company commands nearly half of India’s digital-payments landscape. But its financials trail its smaller, listed rival
As the logistics firm plans to pour IPO money into new warehouses and long leases, incumbents are squeezing returns from assets they locked in when land was cheaper, and rents were lower
The Ken has learnt that the Centre is holding deeper discussions on allowing private schools to run as for-profit entities to encourage transparency and long-term steady growth
A complex system with feedback loops that pulls us towards a future we imagine possible
Private labels meet brand ambition
So far, only Wechat seems to have cracked the code to creating an apps-within-an-app ecosystem. Can AI take it to the rest of the world?
The IT services firm is seeking a secondary listing to match the valuation of its Indian rivals. But logistical and regulatory challenges lie in the way
The co-founder on how Darwinbox grew quietly before it grew big
In this episode, we unpack the rise of what we are calling the “fitness warrior”. This is a new professional archetype where work follows the same logic as sport: optimise, train, perform.
As India’s data law kicks in, WhatsApp outreach is getting regulated, and a new compliance market is emerging fast
The IT services firm is seeking a secondary listing to match the valuation of its Indian rivals. But logistical and regulatory challenges lie in the way
The Sequoia-backed cross-border remittance startup Aspora wants to win over 15 million NRIs at all costs, and it has to decide which cost it wants to bear—regulatory or cross-border realities
The Supreme Court’s recent guidelines and a state’s AI mandate hint at a fragmented overhaul—one testing whether tech can cut through decades of procedural drag
Here are the ones—whether it’s The Nutgraf, Long and Short, or Trade Tricks—that you didn’t expect
Here are the stories that our subscribers read and shared the most in 2025
Here are some of the episodes—across our six different podcasts—that listeners loved
Do you know anyone else who would like to listen this podcast?
Share this episode with them.